Russian Agricultural Sciences Биологические науки

Follimag® Product Effects on Silver Fox Reproductive Performance

Balakirev, N. A., Larina, E. E., Orlova, E. A., Shumilina, N. N., Galatskaya, A. A.
Springer Nature · 2026-04-01 · DOI 10.3103/s1068367426700400

Аннотация

Abstract The studies focus on proving the reasonable application of the Follimag® product, optimizing conditions for the product usage to increase reproductive efficiency of the Savvatievsky silver foxes with irregular or delayed estrous cycles, and assessing the male hormonal stimulation effects on reproduction through artificial insemination. The experiment was conducted on the fur breeding farm in the Tver oblast from 2014 to 2024. The experimental group females ( n = 60) having no estrus by certain dates determined on the farm were injected subcutaneously with 200 IU Follimag®, while the specimens in the control group ( n = 60) did not receive any stimulation. The effect of a single-dose study-drug intramuscular injection administered to 30 males on reproduction through intrauterine artificial insemination was separately assessed. With respect to the adult females in the experimental group, the proportion of specimens that whelped successfully exceeded the control by 4%. The fertility rate and the number of live fox kits per breeding female were higher by 0.6 kits and 0.25 heads, respectively. Stimulation could reduce the mating period in the young and adult females by 9 days and 9–10 days, respectively ( P > 0.999). An increase in the proportion of stillborn kits (by 8.6%) and a higher fox kit mortality rate before registration (by 15.5%) were observed. The effect of stimulation used for five years in the adult females tended to decrease by the fifth year, since the proportion of females that whelped successfully within the experiment became 5.6% lower than that for the control. Stimulation of males contributed to increasing the number of live fox kits per breeding female by 0.5 heads ( P > 0.99). The Follimag® product is not recommended for usage in females without any estrous cycle disorders because of the risk of hormonal imbalance and the long-term reproductive efficiency reduction.

Читать у издателя →